Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy

NCT00754143 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Diabetic Nephropathy

Interventions

DRUG: FG-3019
DRUG: FG-3019
DRUG: FG-3019

Sponsor

Kyntra Bio